![]() |
CTC ADN - Medications in Obstetrics for Nursing Students |
| Click on the linked titles to sort by that field | |||||
|
Category
Sort Hide |
Generic Name
Sort UnHide |
Trade Name
Sort Hide |
Classification
Sort Hide |
Reason
Sort |
Effects on Mom/Baby |
| Antepartum | Electrolyte replacement | Antidote for hypermagnesium | |||
| Usual dose: 1g IV over 3-5 mins | |||||
|
| |||||
| Antepartum | Betamethosone | Steriod | Lung maturity | Increase fetal lung maturity | |
| 12.5mg IM q 24 hrs x 2 doses. Given to mom when PTL (24 - 34 wks) | |||||
|
| |||||
| Antepartum | Prostin E2 | Prostaglandin | Termination of pregnancy | n/v/d, fever | |
| May be premedicated with Tylenol, antidiarrheal and antiemetic | |||||
|
| |||||
| Antepartum | Apresoline | Antihypertensive | BP control | ||
| Given IVP for acute hypertension. | |||||
|
| |||||
| Antepartum | Ativan | CNS Agent | Anticonvulsant Tx | ||
| Used during seizure. Must be kept refrigerated. | |||||
|
| |||||
| Antepartum | Anticonvulsant | Anticonvulsant Tx; Tx of PTL | During loading dose: Facial flushing, warmth. During tx: hypermagnesium (loss of reflexes, resp arrest, cardiac arrest) | ||
| First choice during seizure and anti-seizure; Also used for PTL. DTRs 1st sign of hypermagnesia; Therapeutic level 4-8 mg/dl. Given thru infusion pump | |||||
|
| |||||
| Antepartum | Aldomet | Antihypertensive | BP control | ||
| DOC for antihypertension maintenance | |||||
|
| |||||
| Antepartum | Procardia | Calcium-channel blocker | Tocolytis; BP Control | Hypotension, tachycardia, facial flushing, h/a | |
| Off-label use for tocolysis. Co-administration with Ritodrine or Terbutaline OK. Do not give with MgSO4. Check BP prior to administering | |||||
|
| |||||
| Antepartum | Yutopar | Tocolytic | Tocolysis | Hypotension, tachycardia, palpitations, pulmonary edema, facial flushing. Fetal tachycardia. | |
| Given IV thru infusion pump titration first. Then moved to PO. Not used much anymore. | |||||
|
| |||||
| Antepartum | Brethine | Tocolytic | Tocolysis | Hypotension, tachycardia, palpitations, pulmonary edema, facial flushing. Fetal tachycardia. | |
| Given IV thru infusion pump titration. Then moved to PO. May use SQ doses for acute, short-term use. Used 2nd most after MgSO4 | |||||
|
| |||||
| Intrapartum | Marcaine | Local anesthetic | Epidural anesthesia | Complications r/t hypotension episode with epidural | |
| Most have BP monitored frequently (q 15 mins) with epidural anesthesia. | |||||
|
| |||||
| Intrapartum | Duramorph Morphine | Narcotic analgesic | Pain relief (surgical) | Sedation | |
| Duramorph placed in epiddural line for continued pain relief up to 24 hrs. Morphine usual drug in PCA. Also given in RR for pain relief. | |||||
|
| |||||
| Intrapartum | Anaprox | NSAID | Pain relief | ||
|
| |||||
| Intrapartum | Percocet | Combination analgesic | Pain relief | Sedation | |
|
| |||||
| Intrapartum | Rhogam | Immunoglobulin | Prevention of development of antibodies to fetus's Rh-positive blood | ||
| Given antepartum to mom who is Rh negative: at 28 wks and after amnio or abortion; and to Rh negative mom at delivery who's baby is Rh positive. | |||||
|
| |||||
| Newborn | Survanta | Lung surfactant | Improve lung surfactant to decrease incidence of RDS | ||
| Given intratracheal only within 15 mins of birth; rescue given within 8 hrs of age. Indicated for infants 600-1750g | |||||
|
| |||||
| Newborn | Stadol | Narcotic analgesic | Pain relief | Sedation. Can cause transient loss of FHR variability. Neonatal resp if given close to delivery | |
|
| |||||
| Newborn | Antibiotic | Prevention of neonatorum ophthalmia | |||
| Prevention blindness from gonorrhea, Chlamydia. Should be given within first hr of life. State Law | |||||
|
| |||||
| Newborn | Sublimaze | Narcotic analgesic | Synergistic effect with epidural | Not absorbed systemically. Adverse effects r/t hypotension w/epidural | |
| Small amts added to epidural anesthesia. | |||||
|
| |||||
| Newborn | Recombivax HB | Vaccine | Prevention of HepB | ||
| Recommended within 1st 12 hrs after birth. Series of vaccines. | |||||
|
| |||||
| Newborn | Demerol | Narcotic Analgesic | Pain relief | Sedation. Can cause transient loss of FHR variability. Neonatal resp if given close to delivery | |
|
| |||||
| Newborn | Cytotec | Prostaglandin | Cervical ripening | Can cause uterine hyperstimulation | |
| Approved as antiulcer. Off-label use in OB. Also used as abortifacient in 2nd trimester. | |||||
|
| |||||
| Newborn | Nubain | Narcotic Analgesic | Pain relief | Sedation. Can cause transient loss of FHR variability. Neonatal resp if given close to delivery | |
|
| |||||
| Newborn | Narcan | Narcotic antagonist | Reversal of resp depression r/t narcotics | ||
| Given IM. Must assure neonatal dosage. | |||||
|
| |||||
| Newborn | Pitocin | Oxytoxic | Labor induction; Prevention of PPH | R/T hyperstimulation | |
| Given IV thru infustion pump titration. 1st line of drug for prevention t/x of PPH | |||||
|
| |||||
| Newborn | Aqua Mephyton | Vitamin K | Prevention of hemorrhagic dx of the newborn | ||
| Given IM within 1st hr of life. | |||||
|
| |||||
| Newborn | Phenergan | Antiemetic | Prevention/tx of n/v Synergistic with narcotics | Can cause extrapyramidal effects. Use lowest dose | |
|
| |||||
| Newborn | Local anesthetic | Episotomy | |||
| w/o epinephrine | |||||
|
| |||||
| Postpartum | Hemabate | Prostaglandin | Severe PPH | ||
| 3rd line of drug for PPH | |||||
|
| |||||
| Postpartum | Colace | Stool softner | Prevention of constipation | ||
|
| |||||
| Postpartum | Feosol | Iron replacement | Prevention/tx of anemia | May turn stools dark. | |
| Take with Vit C to increase absorption | |||||
|
| |||||
| Postpartum | Motrin | NSAID | Pain relief | ||
|
| |||||
| Postpartum | Depoprovera | Progestin | Birth Control | ||
| Given q 3 months IM | |||||
|
| |||||
| Postpartum | Rubella vaccine | Vaccine | Prevention of rubella | ||
| Give PP only. | |||||
|
| |||||
| Postpartum | Methergine | Oxytocic | PPH | May increase BP | |
| 2nd line of drug for PPH (IV). Can be continued PO. | |||||
|
| |||||